Cardurion Pharmaceuticals

Cardurion’s page covers CaMKII inhibition as a cardiovascular target and the company’s clinical testing of a CaMKII inhibitor for heart diseases.

Cardurion’s page provides information about its cardiovascular research and clinical trials, including participation in studies for heart disease.

Cardurion’s approach to PDE9 inhibition for heart failure targets the natriuretic peptide pathway to improve cardiac function.

AHA 2023 publication: CaMKII inhibitors reduce substrate phosphorylation and prolong survival in heart failure mouse models. Cardurion research.

Cardurion Pharmaceuticals appointed Chris Morabito, M.D., as chief medical officer.

Cardurion Pharmaceuticals appointed Howard K. Surks, M.D., as chief scientific officer.

Cardurion Pharmaceuticals appointed Peter S. Lawrence as president and chief executive officer.

CARDINAL-HF is a Phase 2 proof-of-concept trial of Cardurion’s PDE9 inhibitor CRD-740 in heart failure. The trial examines its effects in both types of heart failure and in key patient subsets.

Cardurion offers career opportunities on its team developing cardiovascular therapies.

The page introduces Cardurion’s board of directors, which guides development of cardiovascular therapeutics.

The page introduces Cardurion’s leadership team, comprising physician-scientists and industry veterans with expertise in cardiovascular science and drug development.

Cardurion is a next-generation cardiovascular company founded by physician-scientists, advancing PDE9 and CaMKII programs to address unmet needs in heart disease.

The page introduces Cardurion’s Scientific and Clinical Advisory Boards, whose members guide pipeline development and clinical trials.

Transforming the treatment of cardiovascular disease and heart failure

Cardurion’s Privacy Notice explains how the company collects, uses, and protects personal information and describes privacy rights and data practices.

Cardurion’s European Privacy Notice applies to visitors in the EEA, UK, and Switzerland under GDPR and covers the handling of personal information.

Cardurion’s Terms of Use govern access to its website and set out the conditions and policies for using cardurion.com.